CAR Discovery Service by Yeast Display

Services Workflow Features Related Services Introduction

Are you currently facing challenges in antibody development for your CAR-T cell therapies, such as low hit rates and high off-target binding while trying to achieve the desired affinity? The CAR antibody discovery and evaluation service from Creative Biolabs enables you to resolve development challenges while speeding up the creation of effective CAR-T cell therapies. Our advanced yeast display technology allows us to identify antibodies that possess both high specificity and affinity.

CAR Antibody Discovery and Evaluation

Fig 1. A picture demonstrating CAR-T therapy. (Creative Biolabs Authorized)

Creative Biolabs offers specialized antibody discovery and evaluation services to help speed up your CAR-T cell therapy projects. Utilizing sophisticated yeast display technology, we accurately select antibodies with both high specificity and affinity to target your chosen antigen. The platform delivers high-throughput screening capabilities along with rapid affinity maturation and functional validation which creates a seamless transition from discovery to optimization. Through precise data delivery combined with transparent communication and timely project completion, we strive to support your research demands and boost CAR-T cell therapy development success.

Workflow

Creative Biolabs delivers CAR antibody candidates through an efficient workflow that meets your targeted specifications.

Initial Consultation & Design Discussion

Discuss with the client the target antigen, project goals, research requirements, technical specifications, and determine the experimental design.

Library Construction

From various sources, including immunized animals or synthetic genes.
Construct antibody library (e.g., scFvs, Fabs, or sdAbs), cloning into yeast display vectors.
Transform yeast cells, display antibodies on their surface, linking genotype to phenotype.

Screening and Enrichment

Screening of yeast displayed high-affinity, specific binders.

Characterization and Validation

Characterize selected candidates: affinity, specificity, developability.

CAR-T Construct Design

Incorporate optimized antibody sequence into CAR-T constructs.

Functional Validation

CAR-T cell functionality testing and assays.

Final Deliverables

Provided report: antibody sequences, affinity, specificity and CAR-T design.
Deliver purified antibodies/CAR-T constructs.

Why Choose Us?

High throughput & Efficiency

Screening of large antibody libraries (up to 109 variants) quickly and enable fast identification of high-affinity antigen binders.

Functional Antibody Selection

Select antibodies based on both binding affinity and functional interaction with target antigens.

Versatility

Adaptable to a wide range of antigens, from small peptides to complex membrane proteins, suitable for diverse CAR T-cell projects.

Rapid Affinity Maturation

Allow quick iterations to fine-tune antibody affinity and specificity, meeting CAR development standards.

Humanization & Optimization

Discovered antibodies can be humanized to reduce immunogenicity, ensuring compatibility with human immune systems in CAR-T cells.

Related Services

Our services encompass various antibody discovery and evaluation applications, addressing a wide array of needs in antibody development, including but not limited to:

Introduction

CAR-T cell therapy transformed cancer treatment because it allows T-cells to precisely attack tumor antigens. The success of CAR-T cell therapy depends on how high-quality the CAR antibody is. Scientists face difficulties finding high-affinity and high-specificity antibodies because tumor antigens are complex and CAR-T therapies require optimal antibody function.

Yeast Display technology represents a sophisticated platform that solves these research and development challenges. Technology supports the fast assessment of vast antibody collections (up to 10⁹ variants) for interaction with tumor antigens which assists in discovering antibody candidates with high functionality and affinity. Yeast display technology creates stable antibodies that bind challenging antigens effectively which positions it as an essential tool for developing CAR-T cells.

Get in Touch with Us Today

Contact us today to learn how our expertise in Yeast Display technology can accelerate your CAR-T cell therapy development. We offer tailored solutions, valuable insights, and competitive pricing to meet all your project needs. Partner with us to achieve impactful results that align with your research goals.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: